These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2154996)

  • 21. Phenotypic analyses and concanavalin-A-induced suppressor cell dysfunction of intrathyroidal lymphocytes from patients with Graves' disease.
    Ueki Y; Eguchi K; Otsubo T; Kawabe Y; Shimomura C; Matsunaga M; Tezuka H; Nakao H; Kawakami A; Izumi M
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1018-24. PubMed ID: 2972737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistological characteristics of T cell infiltrates in different forms of childhood onset chronic arthritis.
    Murray KJ; Luyrink L; Grom AA; Passo MH; Emery H; Witte D; Glass DN
    J Rheumatol; 1996 Dec; 23(12):2116-24. PubMed ID: 8970050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoregulatory T cells in man. Histamine-induced suppressor T cells are derived from a Leu 2+ (T8+) subpopulation distinct from that which gives rise to cytotoxic T cells.
    Sansoni P; Silverman ED; Khan MM; Melmon KL; Engleman EG
    J Clin Invest; 1985 Feb; 75(2):650-6. PubMed ID: 3156150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppressor T cell numbers and function in atopic patients with high serum IgE levels.
    Armitstead JG; Ewan PW
    J Clin Lab Immunol; 1983 Dec; 12(4):179-85. PubMed ID: 6229638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis.
    Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
    Clin Dev Immunol; 2006; 13(2-4):283-7. PubMed ID: 17162369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired concanavalin A-inducible suppressor T-cell activity in active alcoholic liver disease.
    Kawanishi H; Tavassolie H; MacDermott RP; Sheagren JN
    Gastroenterology; 1981 Mar; 80(3):510-7. PubMed ID: 6450078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of low dose cyclophosphamide on the immune system of cancer patients: reduction of T-suppressor function without depletion of the CD8+ subset.
    Berd D; Mastrangelo MJ
    Cancer Res; 1987 Jun; 47(12):3317-21. PubMed ID: 2953413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of OKT4 suppressor cells in the autologous mixed lymphocyte reaction of patients with juvenile rheumatoid arthritis.
    Oen K; Krzekotowska D
    Clin Exp Immunol; 1987 Jul; 69(1):57-67. PubMed ID: 2958194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Histamine receptor-bearing lymphocytes. V. Induction of suppressor cells with histamine or concanavalin A].
    Volk HD; Grunow R; Eckert R
    Allerg Immunol (Leipz); 1986; 32(2):97-102. PubMed ID: 2942024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppressor cell responses in patients with rheumatoid arthritis: the effect of thymosin.
    Zatz MM; Oliver J; Goldstein AL; Novak C; Jacobs RP
    Thymus; 1984; 6(4):205-18. PubMed ID: 6238454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic effects of autacoids on subsets of T cells. Regulation of expression/function of histamine-2 receptors by a subset of suppressor cells.
    Khan MM; Sansoni P; Engleman EG; Melmon KL
    J Clin Invest; 1985 May; 75(5):1578-83. PubMed ID: 2860125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decrease of concanavalin-A activated and short lived suppressor T cell function in thyrotoxicosis.
    Balázs C; Leövey A; Bordan L
    Biomedicine; 1979 Jul; 30(3):143-7. PubMed ID: 158395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous improvement of juvenile rheumatoid arthritis after T lymphocytosis with suppressor phenotype and function.
    Ichikawa M; Yanagisawa M; Kawai H; Kamijo T; Komiyama A; Akabane T
    J Clin Lab Immunol; 1988 Dec; 27(4):197-201. PubMed ID: 2977987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic modulation in vitro of human histamine-induced suppressor cell activity.
    Rocklin RE; Habarek-Davidson A
    Int J Immunopharmacol; 1984; 6(3):179-86. PubMed ID: 6086538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and reduced lipoprotein-associated platelet-activating factor acetylhydrolase activity.
    Tselepis AD; Elisaf M; Besis S; Karabina SA; Chapman MJ; Siamopoulou A
    Arthritis Rheum; 1999 Feb; 42(2):373-83. PubMed ID: 10025933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phospholipase A2 in juvenile rheumatoid arthritis: correlation to disease type and activity.
    Pruzanski W; Albin-Cook K; Laxer RM; MacMillan J; Stefanski E; Vadas P; Silverman ED
    J Rheumatol; 1994 Oct; 21(10):1951-4. PubMed ID: 7837165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating immune complexes and antinuclear antibodies in juvenile rheumatoid arthritis.
    Rossen RD; Brewer EJ; Person DA; Templeton JW; Lidsky MD
    Arthritis Rheum; 1977; 20(8):1485-90. PubMed ID: 303520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer (NK) cell activity of peripheral blood, synovial fluid, and synovial tissue lymphocytes from patients with rheumatoid arthritis and juvenile rheumatoid arthritis.
    Dobloug JH; Førre O; Kvien TK; Egeland T; Degré M
    Ann Rheum Dis; 1982 Oct; 41(5):490-4. PubMed ID: 6181746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biologic agents for the treatment of juvenile rheumatoid arthritis: current status.
    Carrasco R; Smith JA; Lovell D
    Paediatr Drugs; 2004; 6(3):137-46. PubMed ID: 15170361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
    Kammer GM; Birch RE; Polmar SH
    J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.